An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD
Clinical trial NCT06987851 · COMPLETED
Trial details
- NCT number
- NCT06987851
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2024-05-16
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.